12.54
Schlusskurs vom Vortag:
$12.74
Offen:
$12.83
24-Stunden-Volumen:
452.49K
Relative Volume:
0.25
Marktkapitalisierung:
$1.62B
Einnahmen:
$3.31B
Nettoeinkommen (Verlust:
$98.90M
KGV:
-20.45
EPS:
-0.6131
Netto-Cashflow:
$195.60M
1W Leistung:
-6.10%
1M Leistung:
-18.86%
6M Leistung:
-42.64%
1J Leistung:
-46.87%
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SGRY
Surgery Partners Inc
|
12.54 | 1.65B | 3.31B | 98.90M | 195.60M | -0.6131 |
|
HCA
Hca Healthcare Inc
|
536.26 | 119.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
224.04 | 19.54B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.82 | 12.71B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
210.57 | 12.11B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
193.34 | 11.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Surgery Partners appoints Lloyd Dean to board of directors By Investing.com - Investing.com India
Surgery Partners appoints Lloyd Dean to board of directors - Investing.com
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors - Bitget
Surgery Partners, Inc. Appoints Lloyd Dean as Independent Director to Board of Directors - Quiver Quantitative
Surgery Partners (SGRY) Is Down 9.7% After Soft 2026 Outlook And New Buyback PlanHas The Bull Case Changed? - Yahoo Finance
Assessing Surgery Partners (SGRY) Valuation After Activist Pressure And Mixed Earnings Updates - simplywall.st
Deals tracker: Aveanna Healthcare to acquire Family First Healthcare - Modern Healthcare
Surgery Partners (SGRY) Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates - GlobeNewswire
Ortelius Targets Surgery Partners Governance While Shares Screen As Undervalued - Yahoo Finance
UBS Maintains Buy on Surgery Partners (SGRY) on March 11, 2026 - Meyka
UBS reiterates Surgery Partners stock rating after activist letter By Investing.com - Investing.com Canada
Activist investor calls for Surgery Partners leadership change By Investing.com - Investing.com Canada
Surgery Partners at Barclays Healthcare Conference: Strategic Plans Amid Challenges - Investing.com
Activist Ortelius pushes for board changes, asset sales at Surgery Partners - MSN
Ortelius Capital Management recently proposed a series of strategic adjustments for Surgery Partners, Inc., including a comprehensive overhaul of the board structure, the introduction of a new management team, and a systematic evaluation of the company’s - Bitget
Ortelius Delivers Open Letter To Surgery Partners Stockholders - TradingView
Ortelius Delivers Open Letter to Surgery Partners Stockholders - The Joplin Globe
Activist urges Surgery Partners to sell hospitals and raise billions - Stock Titan
Surgery Partners to Present at Barclays Healthcare Conference - National Today
Precision Trading with Surgery Partners Inc. (SGRY) Risk Zones - Stock Traders Daily
Surgery Partners, Inc. $SGRY Stock Position Decreased by Gabelli Funds LLC - MarketBeat
Surgery Partners’ Webb sells $28,653 in shares By Investing.com - Investing.com Australia
Burkhalter, Surgery Partners CHRO, sells $105k in shares By Investing.com - Investing.com Nigeria
William Trenton Webb Sells 1,794 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Marissa Brittenham Sells 8,785 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
David Doherty Sells 14,574 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Jennifer Baldock Sells 10,082 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Surgery Partners (NASDAQ:SGRY) CEO Sells $158,060.98 in Stock - MarketBeat
Baldock of Surgery Partners sells $138k in shares - Investing.com
Surgery Partners CFO Doherty sells $201,704 in shares By Investing.com - Investing.com UK
Surgery Partners CFO Doherty sells $201,704 in shares - Investing.com
Baldock of Surgery Partners sells $138k in shares By Investing.com - Investing.com UK
Surgery Partners, Inc. to Present at Upcoming Investor Conference - marketscreener.com
Hear Surgery Partners’ Barclays healthcare presentation live online - Stock Titan
Outpatient Care Q4 2025: Mixed Earnings, Surgery Partners Revenue UpNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25 - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Lowers Holdings in Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners Faces Weak Start with 21.85% Gap Down Amid Market Concerns - Markets Mojo
Day Trade: Is Surgery Partners Inc affected by consumer sentimentJuly 2025 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
Assessing Surgery Partners (SGRY) Valuation After Recent Share Price Weakness And Undervalued Narrative - Sahm
TD Cowen Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $20.00 - MarketBeat
SGRY Stock: TD Cowen Lowers Price Target to $20.00, Maintains Bu - GuruFocus
Analyst Expectations For Surgery Partners's Future - Benzinga
UBS Group Issues Pessimistic Forecast for Surgery Partners (NASDAQ:SGRY) Stock Price - MarketBeat
UBS Maintains 'Buy' Rating for Surgery Partners (SGRY), Lowers P - GuruFocus
UBS Adjusts Price Target on Surgery Partners to $21 From $29, Maintains Buy Rating - marketscreener.com
SGRY: Mizuho Lowers Price Target to $17, Maintains Outperform Ra - GuruFocus
Surgery Partners (NASDAQ:SGRY) Price Target Cut to $17.00 by Analysts at Mizuho - MarketBeat
Surgery Partners acquires dialysis access provider for $6B market By Investing.com - Investing.com Canada
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):